Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension

Omboni, Stefano; Riva, Isabella; Giglio, A.; Caldara, G; Groppelli, Antonella; Parati, Gianfranco

doi:10.1097/mbp.0b013e32813fa386

Cited by 111 publications

(77 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although statistically significant, these differences are very small and should have little impact in the clinical setting or in epidemiologic studies. Our results are consistent with those of some 10,11 , but not all studies on other Omron devices [12][13][14][15] . We also found that the Omron HEM-705 CP qualifies as a grade A device for measuring blood pressure, according to the BHS protocol criteria 1,2 .…”

Section: Discussionsupporting

confidence: 93%

Precisão do aparelho Omron HEM-705 CP na medida de pressão arterial em grandes estudos epidemiológicos

Vera-Cala¹,

Oróstegui²,

Valencia-Angel³

et al. 2011

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

Background: Accurate measurement of blood pressure is of utmost importance in hypertension research. In the context of epidemiologic and clinical studies, oscillometric devices offer important advantages to overcome some of the limitations of the auscultatory method. Even though their accuracy has been evaluated in multiple studies in the clinical setting, there is little evidence of their performance in large epidemiologic studies.

show abstract

Section: Discussionsupporting

confidence: 93%

Precisão do aparelho Omron HEM-705 CP na medida de pressão arterial em grandes estudos epidemiológicos

Vera-Cala¹,

Oróstegui²,

Valencia-Angel³

et al. 2011

Arq. Bras. Cardiol.

View full text Add to dashboard Cite

show abstract

“…15,16 All of the tonometry data were stored and uploaded via a file transfer protocol mechanism to a central server and reviewed by a single core laboratory member to ensure adequate waveform quality for analysis. Augmentation index was calculated as the ratio of the second and first radial systolic pressure peaks.…”

Section: Radial Artery Tonometrymentioning

confidence: 99%

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

et al. 2010

View full text Add to dashboard Cite

Abstract-Diastolic dysfunction may precede development of heart failure in hypertensive patients. We randomized 228 patients with uncontrolled hypertension, preserved ejection fraction, and diastolic dysfunction to 2 targeted treatment strategies: intensive, with a systolic blood pressure target of Ͻ130 mm Hg, or standard, with a systolic blood pressure target of Ͻ140 mm Hg, using a combination of valsartan, either 160 or 320 mg, plus amlodipine, either 5 or 10 mg, with other antihypertensive medications as needed. any of the adverse sequelae of hypertension are the direct result of target-organ damage to the vasculature, the kidneys, and the heart. In the heart, long-standing hypertension serves as a stimulus for progressive fibrosis, ventricular hypertrophy, 1-3 and diastolic dysfunction, which may be one of the earliest manifestations of cardiac target-organ damage. 4 These changes may be accelerated by age and hypertension-related changes in central aortic stiffness, which may contribute to abnormal pulse wave reflection and enhanced pulsatile arterial load. Present in Յ50% of hypertensive patients, diastolic dysfunction likely represents an important intermediate in the development of heart failure, particularly in patients with preserved systolic function. 5,6 We have demonstrated previously that blood pressure lowering in patients with stage 1 hypertension is associated with improvement in diastolic function, whether a renin-angiotensin-aldosterone system inhibitor or non-renin-angiotensin-aldosterone system blood pressure lowering was used. 7 Because the degree of improvement in diastolic function appears to be closely tied to the degree of blood pressure lowering, we hypothesized that a strategy of aggressive blood pressure control (beyond the established Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure targets 8 ) would be more effective than a less intensive strategy in attenuating cardiac dysfunction. More aggressive targets have already been recommended in certain subgroups of patients, including those with diabetes mellitus, chronic kidney disease, and coronary artery disease. 9 The Exforge Intensive Control of Hypertension to Evaluate Efficacy in Diastolic Dysfunction (EXCEED) Trial was designed to prospectively test the hypothesis that, among patients with uncontrolledContinuing medical education (CME) credit is available for this article. Go to http://cme.ahajournals.org to take the quiz. The principal investigator and steering committee wrote the article, made the decision to submit for publication, and take responsibility for its contents. This trial has been registered at www.clinicaltrials.gov (identifier NCT00523549).

show abstract

“…[2][3][4] It has distinct advantages in sub-populations in which automated oscillometric device readings are less accurate, particularly for those with conditions such as diabetes, 5 arrhythmias, 6 pre-eclampsia 7 and for the elderly. 8 Since its proposal in 2001, various hybrid devices 9,10 have been manufactured and validated. These devices provide a mercury-free, electronic pressure display that enables manual auscultatory BP measurement through the simulation of an aneroid display (Accoson Green-light, 11 A.C. Cossor & son Ltd., Essex, UK), a falling mercury column (A&D UM-101, 12 A&D Company Ltd., Tokyo, Japan), or a large numeric digital LCD (liquid crystal display) (Rossmax Mandaus II, Rossmax International Ltd., Taipei, Taiwan, 13 PMS Mandaus, 14 PMS Instruments Ltd., Berkshire, UK).…”

Section: Introductionmentioning

confidence: 99%

Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000

2010

View full text Add to dashboard Cite

Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension

Abstract: According to the results of the validation study based on the European Society of Hypertension International Protocol the Omron M5-I, R5-I, and HEM-907 may be recommended for clinical use in elderly individuals, without atrial fibrillation or frequent ectopic beats.

Cited by 111 publications

References 29 publications

Precisão do aparelho Omron HEM-705 CP na medida de pressão arterial em grandes estudos epidemiológicos

Precisão do aparelho Omron HEM-705 CP na medida de pressão arterial em grandes estudos epidemiológicos

Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction

Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000

Contact Info

Product

Resources

About